![John Thompson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Thompson
Direktor/Vorstandsmitglied bei
NERVGEN PHARMA CORP.
Vermögen: 250 002 $ am 31.05.2026
Profil
John Craig Thompson is Chief Executive Officer & Director at Cerevance, Inc. since 2022.
Mr. Thompson is Independent Director at Esperion Therapeutics, Inc. starting in 2025.
Mr. Thompson is Independent Non-Executive Director at NervGen Pharma Corp.
since 2022.
Former roles include President, Chief Executive Officer & Director at Anthera Pharmaceuticals, Inc. from 2016 to 2018.
President & Chief Executive Officer at Neurana Pharmaceuticals, Inc. Vice President-Marketing at Pfizer Inc. from 2003 to 2010.
Chief Operating Officer at Tetraphase Pharmaceuticals, Inc. from 2014 to 2015.
Chief Commercial Officer at Trius Therapeutics, Inc. Education includes an MBA from the University of Notre Dame and an undergraduate degree from McMaster University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.05.2026 | 79’873 ( 0.03% ) | 250 002 $ | 31.05.2026 | |
NERVGEN PHARMA CORP. -.--% | 16.05.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von John Thompson
| Unternehmen | Position | Beginn |
|---|---|---|
| NERVGEN PHARMA CORP. | Direktor/Vorstandsmitglied | 13.04.2022 |
| ESPERION THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.07.2025 |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Vorstandsvorsitzender | 01.04.2022 |
Ehemalige bekannte Positionen von John Thompson
| Unternehmen | Position | Ende |
|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 30.06.2018 |
| TETRAPHASE PHARMACEUTICALS, INC. | Geschäftsführer | 31.12.2015 |
| PFIZER INC. | Vertrieb & Marketing | 01.01.2010 |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Vorstandsvorsitzender | - |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Corporate Officer/Principal | - |
Ausbildung von John Thompson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
